At a glance
ClinicalIndex Comparison RecordPhase 2Completed
Drug / intervention
chemotherapy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Positive Ph Acute Lymphoblastic Leucemia With Intensive Induction Chemotherapy and Glivec, Before and After the Hematopoetic Progenitor Transplant
In Brief
A Phase 2 clinical trial evaluating chemotherapy and Glivec for Acute Lymphoblastic Leukemia and Cromosome Philadelphia Positive. Completed, across 28 sites.
Detailed Summary
% positive Ph LLA with RC alter the Glivec and induction chemotherapy treatment
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--
Timeline
Phase 2CompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJun 2002
Primary CompletionOct 2006
First PostedOct 2006
Study CompletionOct 2007
TodayJul 2026
First PostedOct 17, 2006
Enrollment StartJun 1, 2002
Primary CompletionOct 1, 2006
Study CompletionOct 1, 2007
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 19.7 years ago
Interventions
chemotherapydrug
Glivecdrug